ArticleIndian pediatrics2026
Development and Validation of Obesity Interpreter: A Mobile Application-Based Tool for Children and Adolescents.
Article in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adolescent Obesity: A Stepwise Clinical Approach.Indian journal of pediatrics · 2026Review
- Weight Loss and Metabolic Remission in Obese Children with MASLD: Reflections on the Use of ALT and Cohort Selection.Indian pediatrics · 2026Article
- Obesity Interpreter: A Digital Tool for Assessment of Childhood Obesity.Indian pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and validate Obesity Interpreter, a mobile application tool to assist in assessing children with obesity and avoid unwarranted workup in physiological obesity.
methodsThe Obesity Interpreter offers guidance on probable diagnoses and workup based on clinical inputs. The validation involved comparing the guidance from the Obesity Interpreter, a pediatric endocrinologist, a pediatrician, and a trainee on the final diagnosis (gold standard) in 400 children and adolescents with obesity concerns (270 constitutional, 23 genetic/syndromic, 11 drug-induced, 13 endocrine, 83 normal or overweight).
resultsThe concordance scores were higher for the endocrinologist (92.1%) and the Obesity Interpreter (99.5%) compared to the pediatrician (75.4%) and the trainee (56.6%). The workup guidance of the Obesity Interpreter aligned with the gold standard in 398 (99.5%) subjects (Cohen's kappa 0.989, 95% CI 0.971, 1.0). Diagnostic workup discrepancies were noted in 83 (20.8%) subjects by the pediatrician and in 162 (40.5%) subjects by the trainee. Utilizing the mobile application would have prevented 288/ 292 (98.6%) errors observed in the study with high agreement for classification recommendation (Cohen's kappa 0.990, 95% CI 0.975, 1.0).
conclusionObesity Interpreter provided guidance aligned with the gold standard for evaluation of children with obesity.
Indexed as
Identifiers
41915137What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.